GOP Blocks Review of AI in Medicare Prior Authorization

A recent decision by Republican members of Congress to block efforts to end Medicare’s test of AI-driven prior authorization systems leaves a critical area of health policy without immediate legislative scrutiny. The move means that the Centers for Medicare & Medicaid Services (CMS) will continue its pilot programs using AI to streamline or deny medical service requests for beneficiaries, a practice that has drawn concern from healthcare providers and patient advocacy groups alike. The pilot programs, which began in 2023, aim to reduce administrative burdens and costs, but critics argue they could inadvertently create barriers to necessary care.

The controversy centers on transparency and accountability. While AI promises efficiency, its application in determining patient eligibility for treatments and diagnostics raises questions about algorithmic bias and the potential for wrongful denials. The American Medical Association (AMA) has frequently highlighted that prior authorization processes, regardless of whether they are AI-driven or manual, often delay care, with 88% of physicians reporting care delays for patients due to prior authorization in a 2021 survey.

For individual Medicare beneficiaries, this translates into a continued reliance on opaque automated systems to approve or deny services. The stakes are particularly high for those managing complex health conditions or requiring specialized diagnostic tests, where delays can significantly impact outcomes. Without clear guidelines and robust review mechanisms, the potential for AI systems to disproportionately affect vulnerable populations remains a significant concern.